MetLife Investment Management LLC Has $14.95 Million Stake in CVS Health Co. (NYSE:CVS)

MetLife Investment Management LLC grew its stake in CVS Health Co. (NYSE:CVS - Free Report) by 1.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 333,134 shares of the pharmacy operator's stock after buying an additional 5,964 shares during the period. MetLife Investment Management LLC's holdings in CVS Health were worth $14,954,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in CVS. Ridgewood Investments LLC grew its holdings in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC bought a new stake in shares of CVS Health during the 4th quarter worth $28,000. Hopwood Financial Services Inc. acquired a new position in CVS Health in the 4th quarter valued at $29,000. Financial Perspectives Inc lifted its position in CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after acquiring an additional 466 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. boosted its holdings in CVS Health by 112.1% during the fourth quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after acquiring an additional 437 shares during the period. Institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on CVS shares. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Robert W. Baird raised their price objective on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Barclays boosted their price objective on CVS Health from $71.00 to $73.00 and gave the company an "overweight" rating in a research report on Thursday, February 13th. Argus set a $77.00 price target on shares of CVS Health in a research note on Tuesday, February 18th. Finally, Mizuho raised their price objective on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Four analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $71.83.

CVS Health Stock Up 0.2 %

Shares of NYSE CVS traded up $0.13 during mid-day trading on Wednesday, hitting $65.58. The company had a trading volume of 10,832,978 shares, compared to its average volume of 11,842,121. CVS Health Co. has a one year low of $43.56 and a one year high of $71.45. The company has a market capitalization of $82.68 billion, a PE ratio of 17.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm has a 50-day simple moving average of $66.48 and a two-hundred day simple moving average of $58.82.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, equities analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.06%. The ex-dividend date is Tuesday, April 22nd. CVS Health's dividend payout ratio is presently 72.68%.

Insider Activity

In related news, Director Michael F. Mahoney purchased 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.22% of the stock is owned by company insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.